AVP and metabolic dysfunction-associated steatohepatitis: The association between copeptin and NASH persisted statistically significant also after further adjustment for each individual metabolic parameter (BMI, FBG, triglycerides and HDL-c), entered as continuous variables in progressive conditional forward regression models (copeptin-standardized β-coefficient = 0.64, p = 0.035, odds ratio = 1.97, 95% CI = 1.05–3.69; Cox and Snell R2 = 0.56; Additional file 1: Table S3).